Latest News and Press Releases

Vyluma Announces NVK002 Drug Application Acceptance in China

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Myopia And Presbyopia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...

New York, USA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight A  case study on how a leading company...

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Myopia and Presbyopia Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Vyluma Discusses Response to FDA’s Questions and Clarifies Regulatory Pathway for its 505(b)(2) NDA, NVK002 to slow the progression of myopia in children.

Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Myopia Treatment Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Treatment, Age...

Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Intraocular Lens Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...

Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses...

Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Global Prescription Lens Market by Type (Bifocal, Progressive, Single Vision), Coating (Anti-Fog Coating, Anti-Reflective, Scratch Resistant Coating),...

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "North America Vision Care Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...